FSANZ calls for comment on infant formula method
Food Standards Australia New Zealand (FSANZ) is requesting comments on an application it has received to allow a new method of producing an already-used oligosaccharide, 2′fucosyllactose (or 2ʹ-FL for simplicity).
The oligosaccharide is already added to infant formula but the new method would use a different method of production that involves a genetically modified Escherichia coli strain. The resulting 2ʹ-FL is identical to the oligosaccharide that is produced in human milk and the E. coli strain that is being used is also permitted for production of other substances. FSANZ analyses showed no safety concerns or published health issues with the substance.
2ʹ-FL produced by a strain of genetically modified bacteria is already permitted for use and another application for a different strain is currently undergoing assessment.
The submissions for the application will be closed from 6 pm (Canberra Time), 31 January 2022.
To submit a comment regarding this application, this is the page to use. To read more about the application and method, peruse this page and its links.
Expanding beyond biscuits: Arnott's acquires Prolife Foods
The Arnott's Group has expanded its 'better-for-you' snacking portfolio with the...
FDA investigates PFAS in seafood
The US Food and Drug Administration (FDA) expands its investigation on per- and polyfluoroalkyl...
Cell-cultured quail moving closer to Australians' plates
FSANZ is undertaking a second round of consultation on a proposed approach to allow cell-cultured...
